{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:11Z","timestamp":1788871751764,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK137299"],"award-info":[{"award-number":["R01DK137299"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","award":["SCR_020985"],"award-info":[{"award-number":["SCR_020985"]}],"id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118194","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:22:25Z","timestamp":1758576145000},"page":"118194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models"],"prefix":"10.1016","volume":"300","author":[{"given":"Saurabh","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerij","family":"Talagayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wolber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-018-0389-y","article-title":"Mechanisms of resistance to immune checkpoint blockade","volume":"20","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6332","key":"10.1016\/j.ejmech.2025.118194_bib2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118194_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130310","article-title":"CD28 and ICOS in immune regulation: structural insights and therapeutic targeting","volume":"127","author":"Upadhyay","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118194_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/intimm\/7.6.891","article-title":"June CH. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro","volume":"7","author":"Levine","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2025.118194_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100256","article-title":"Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders","volume":"35","author":"Calvo-Barreiro","year":"2025","journal-title":"SLAS Discov"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118194_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ccell.2021.10.008","article-title":"Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation","volume":"39","author":"Duraiswamy","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118194_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177060","article-title":"Novel prospects in targeting neurodegenerative disorders via autophagy","volume":"984","author":"Khan","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118194_bib8","article-title":"Discovery of CD28-Targeted small molecule inhibitors of T cell co-stimulation using affinity selection-mass spectrometry (AS-MS) and ex vivo validation","author":"Upadhyay","year":"2025","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118194_bib9","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood.V92.8.2963","article-title":"Role of CD28 in acute graft-versus-host disease","volume":"92","author":"Yu","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118194_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42003-021-02119-9","article-title":"CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells","volume":"4","author":"Lai","year":"2021","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-065X.2009.00780.x","article-title":"The clinical utility of inhibiting CD28-mediated costimulation","volume":"229","author":"Linsley","year":"2009","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118194_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118194_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcph.791","article-title":"Pharmacokinetic, pharmacodynamic, and safety profile of a novel Anti-CD28 domain antibody antagonist in healthy subjects","volume":"57","author":"Shi","year":"2017","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118194_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10067-008-0964-3","article-title":"Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis","volume":"27","author":"Ostor","year":"2008","journal-title":"Clin. Rheumatol."},{"issue":"5071","key":"10.1016\/j.ejmech.2025.118194_bib17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1496399","article-title":"Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule","volume":"257","author":"Linsley","year":"1992","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118194_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.5429","article-title":"Patient out-of-pocket costs for biologic drugs after biosimilar competition","volume":"5","author":"Feng","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118194_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118194_bib20","series-title":"TRIC-Based High-Throughput Screening Enables the Discovery of Small Molecule CD28 Binders","author":"Calvo-Barreiro","year":"2025"},{"key":"10.1016\/j.ejmech.2025.118194_bib21","article-title":"Surface plasmon resonance (SPR)-based workflow for high-throughput discovery of CD28-Targeted small molecules","author":"Calvo-Barreiro","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118194_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ni1170","article-title":"Crystal structure of a soluble CD28-Fab complex","volume":"6","author":"Evans","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118194_bib23","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/acs.jcim.9b00281","article-title":"PyRod: tracing water molecules in molecular dynamics simulations","volume":"59","author":"Schaller","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118194_bib25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1021\/acs.biochem.5c00009","article-title":"Impact of cancer-associated PKM2 mutations on enzyme activity and allosteric regulation: structural and functional insights into metabolic reprogramming","volume":"64","author":"Upadhyay","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118194_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4939-7465-8_17","article-title":"Investigating small-molecule ligand binding to G protein-coupled receptors with biased or unbiased molecular dynamics simulations","volume":"1705","author":"Marino","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2025.118194_bib27","article-title":"Structural and mechanistic insights into ALS patient derived mutations in D-amino acid oxidase","volume":"256","author":"Khan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118194_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ymthe.2023.11.028","article-title":"Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity","volume":"32","author":"Kennedy","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41525-025-00465-9","article-title":"PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome","volume":"10","author":"Chen","year":"2025","journal-title":"NPJ Genom. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12885-023-10564-4","article-title":"Comprehensive analysis of the role of ICOS (CD278) in pan-cancer prognosis and immunotherapy","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12885-023-10650-7","article-title":"Spatial characterization and quantification of CD40 expression across cancer types","volume":"23","author":"Bates","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1831153","article-title":"Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER export","volume":"9","author":"Chen","year":"2020","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s42003-021-02191-1","article-title":"PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy","volume":"4","author":"Sasikumar","year":"2021","journal-title":"Commun. Biol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118194_bib34","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41590-022-01289-w","article-title":"Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation","volume":"23","author":"Kennedy","year":"2022","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118194_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13578-023-01073-9","article-title":"Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms","volume":"13","author":"Wang","year":"2023","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118194_bib37","article-title":"Antagonist Anti-CD28 therapeutics for the treatment of autoimmune disorders","volume":"6","author":"Vanhove","year":"2017","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.ejmech.2025.118194_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.crstbi.2023.100110","article-title":"Novel peptide inhibitors targeting CD40 and CD40L interaction: a potential for atherosclerosis therapy","volume":"6","author":"Solanki","year":"2023","journal-title":"Curr. Res. Struct. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/prot.22234","article-title":"Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures","volume":"75","author":"Labute","year":"2009","journal-title":"Proteins"},{"issue":"17","key":"10.1016\/j.ejmech.2025.118194_bib40","doi-asserted-by":"crossref","DOI":"10.1063\/1.4872239","article-title":"Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity","volume":"140","author":"Harrach","year":"2014","journal-title":"J. Chem. Phys."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118194_bib41","doi-asserted-by":"crossref","DOI":"10.1063\/1.2943146","article-title":"Implementations of nose-hoover and nose-poincare thermostats in mesoscopic dynamic simulations with the united-residue model of a polypeptide chain","volume":"128","author":"Kleinerman","year":"2008","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118194_bib42","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/S0006-3495(03)74703-1","article-title":"A molecular dynamics method for calculating molecular volume changes appropriate for biomolecular simulation","volume":"85","author":"DeVane","year":"2003","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118194_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118194_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein-ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118194_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T","article-title":"MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries","volume":"20","author":"Halgren","year":"1999","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118194_bib46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118194_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.185.3.393","article-title":"CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics","volume":"185","author":"van der Merwe","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.118194_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117924","article-title":"Lead optimization of a CHI3L1 inhibitor for glioblastoma: enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid models","volume":"297","author":"Kaur","year":"2025","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:45:11Z","timestamp":1773125111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S0223523425009596"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118194","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118194"}}